Hound labs stock prices

Hound labs stock prices DEFAULT

Hound Labs Secures $20M From Entourage Effect Capital To Support Production Of Marijuana Breathalyzer

Hound Labs, Inc., a health tech company, confirmed Friday that it has secured a $20 million investment to support the production of the Hound Marijuana Breathalyzer. 

Its first commercial product, the Hound Marijuana Breathalyzer is the result of the company's patented ultra-sensitive technology capable of detecting recent cannabis use. Not measuring whether or how much a person is impaired, the breathalyzer is intended to be used only in law enforcement, employment and insurance settings.

What makes this technology superior to other testing methods is the ability to detect recent cannabis use by specifically measuring THC. The company noted that testing for THC in a person's breath, where it only remains for several hours before disappearing, is the only way for employers to know whether employees have used cannabis within hours of the test. 

Conventional drug testing of oral fluid, urine and hair can be effective for other drugs, but the cannabis detection window can cause employees to test positive for days, weeks or even months after impairment has subsided.

“The groundbreaking breath testing technology created by Hound Labs provides a substantial competitive advantage to the Company,” said Dov Szapiro, managing partner at Entourage Effect Capital, which led the investment round. “The Hound Labs team has accomplished an impressive scientific achievement – precisely and consistently targeting one specific type of molecule out of the more than 3, different compounds found in breath. Not only are we excited about the immediate capabilities of the Hound® breath technology to measure recent cannabis use, but we are also excited about future applications that can detect pathogens such as SARS-CoV-2 or biomarkers for disease by changing the targeted compound.”

In addition to Entourage Effect Capital, an investment company focused on the cannabis industry, other investors from the round included Intrinsic Capital, Benchmark, Icon Ventures and Tuatara Capital.

Hound Labs emphasized the importance of having a reliable test that can detect recent cannabis use, now that more and more states have legalized recreational marijuana. With little guidance from federal and state governments, employers have been faced with the untenable position of choosing between safety or fairness, the company noted.

Photo: Courtesy of Pavel Lozovikov on Unsplash

Sours: https://www.benzinga.com/markets/cannabis/21/09//hound-labs-securesm-from-entourage-effect-capital-to-support-production-of-marijuana-breathal

Buyer Beware: THC Breathalyzer Won’t Save Cannabix’s Stock

In this week’s Marijuana Market Update, let’s see what Cannabix Technologies Inc.’s patented THC breathalyzer may do for its stock.

Today, I want to address a YouTube question I received from Vincent A. He wrote:

Hey Matt,

Thanks for all the Marijuana Market Updates. Would like to hear what you think about Cannabix Tech (BLOZF), just recently got a U.S. patent for a THC breathalyzer.

Couldn&#;t find much on recent financials, but wondering what your thoughts are? I couldn&#;t find any other publicly-traded company that makes a THC breathalyzer, and with more states legalizing for recreational use, think this might be a good long-term option?

Thanks!

Thank you, Vincent!

About Cannabix Technologies Inc.

Cannabix Technologies Inc. (OTC: BLOZF) trades over the counter in the U.S. and on the Canadian National Stock Exchange.

It’s not a company that cultivates or sells cannabis.

Instead, it creates tools for law enforcement and employers to test for the presence of THC in someone’s system.

Vincent is correct: The company just received a patent for a “Cannabis Drug Detection Device.”

Cannabix has already produced the breathalyzer, and an occupational health clinic in Southern California is performing ongoing field tests.

It works like an alcohol breathalyzer law enforcement uses during traffic stops and car accidents.

An individual blows into the device, and it is supposed the register the amount of THC a person has in their body.

Cannabix THC breathalyzer

It should reduce the THC identification process from days to seconds.

In August, the company said results from its breathalyzer took less than five minutes.

Cannabix officials said they will continue to work on scaling down the current device and decreasing production costs.

The patent is pretty big news for the company as it is now leading the development of this technology.

Cannabix Technologies Stock

Cannabix stock was trading in the $ to $ range for most of the last 12 months.

It ticked up above $ per share in December, as cannabis stocks across the board surged higher amid the changing U.S. political landscape.

As I’ve said before, investors believe that Democratic control of the White House and both Congressional houses will eventually lead to federal decriminalization of cannabis.

However, Cannabix got its biggest boost when it dropped news of its patent award to the public.

THC Breathalyzer Patent Boosts Cannabix Stock Higher

THC breathalyzer Cannabix stock chart

I dive into the financials and why you should proceed with caution for Cannabix’s stock in this week’s video.

The Problem with Cannabix’s Cash Flow

Cannabix doesn’t have any cash flow because it hasn’t really sold anything yet. You can see that in the chart below.

Cannabix Isn’t Making Money

Cannabix cash flow

Overall, this company is a little tricky.

There is another company — Hound Labs — that started on-site testing of its marijuana breathalyzer. The news of this test came just days after Cannabix announced its patent award.

Watch my Marijuana Market Update for a complete analysis of Cannabix’s cash flow and a deep dive into its future.

I’m wary of this stock, but I also know that it’s not alone in the market. Watch my video for more.

Cannabis Watchlist Update

Now, I want to look at our Cannabis Watchlist on Money & Markets.

Our watchlist continues to perform well. Our six positions are averaging more than 40% gains! I explain all the updates to our watchlist in the latest video.

cannabis watchlist January

Where to Find Us

THC breathalyzer Cannabix stock chart

To watch the Marijuana Market Update before anyone else, just subscribe to our YouTube channel and get an alert when we release a new update.

Coming up this week, we’ll have more on The Bull & The Bear podcast and our Money & MarketsWeek Ahead, so stay tuned.

Until next time…

Safe trading,

Clark_Sig

Matt Clark

Research Analyst, Money & Markets

Matt Clark is the research analyst for Money & Markets. He’s the host of our podcast, The Bull & The Bear, as well as the Marijuana Market Update. Before joining the team, he spent 25 years as an investigative journalist and editor — covering everything from politics to business.

Sours: https://moneyandmarkets.com/cannabix-stock-thc-breathalyzer/
  1. Boho duvet covers
  2. Dog picture keychain
  3. Geisinger health insurance reviews
  4. Garmin stock price

Hound Labs Stock

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© EquityZen Inc. All rights reserved.

Sours: https://equityzen.com/company/houndlabs/

First product extension leveraging the Company’s ultra-sensitive breath testing technology

OAKLAND, Calif., Sept. 30, (GLOBE NEWSWIRE) -- Hound Labs, Inc., a medical technology company specializing in point-of-care solutions, announced today the creation of the HOUND COVID BREATHALYZER, the world’s first portable breathalyzer to capture SARS-CoV-2 virus in breath of human test subjects. Hound Labs first successfully used the HOUND COVID BREATHALYZER with hospitalized patients in May The Company’s subsequent research in outpatient settings demonstrated that the most symptomatic people are not always the ones with COVID detectable in breath. The HOUND COVID BREATHALYZER is the Company’s first product extension incorporating the breath testing technology underpinning the Company’s flagship product – the HOUND® MARIJUANA BREATHALYZER.

In early , the Hound Labs scientific team began conducting exploratory research to demonstrate that the Hound technology could successfully be modified to target other substances and markers of disease in breath. In April , based on encouraging results from this research, Hound Labs modified the HOUND® MARIJUANA BREATHALYZER to specifically capture breath samples that would allow for detection of SARS-CoV-2 virus in breath. Breath samples are collected on-location and the test subject self-administers breath collection, minimizing exposure for the Hound Labs research team. Breath samples and a comparative nasal swab are processed using polymerase chain reaction (PCR) in a local laboratory.

“Our team completed the modifications that were necessary to capture breath samples for COVID in approximately six weeks,” stated Dr. Mike Lynn, CEO of Hound Labs, Inc. “This not only demonstrates the extensibility of our technology, but more importantly allowed the Company to confirm that aerosolized particles containing the SARS-CoV-2 virus can be measured in subjects’ breath – even if they are asymptomatic.”

The Hound Labs team continues to conduct IRB-approved research in outpatient settings. Data collected from participants established that the SARS-CoV-2 virus is present in the breath of people who are both symptomatic and asymptomatic. The initial data also demonstrated that the majority of test subjects with COVIDpositive breath samples were younger than 30 years old. The Hound Labs research supports the notion that the SARS-CoV-2 virus is carried on very small aerosol particles. The transmission of COVID via aerosols in breath has profound implications that may ultimately provide a link to “super spreader” events and to those individuals who are more likely to be “super spreaders.” Confirming the link between COVIDpositive breath samples and “super spreaders” will require a large-scale trial to validate the relationship.

The Company’s technology comprises both highly efficient collection and ultra-sensitive detection. A clinical study by scientists at the University of California, San Francisco (UCSF)1 validated that Hound Labs’ proprietary breath technology platform could capture particles in concentrations of parts per trillion or picograms per liter of breath (1 pg/L). While the UCSF research focused on detection of THC (the psychoactive ingredient in cannabis), the study also suggested that the ultra-sensitivity of the Company’s core breath technology could be used for measuring concentrations of biomarkers related to other drugs or illness.

“We are excited about the potential of the Hound Labs technology to directly detect biological analytes of interest. Many breath detection approaches only measure secondary analytes such as volatile gases,” explained Dr. Joe Heanue, CEO of Triple Ring Technologies. “The Hound Labs solution directly captures the SARS-CoV-2 virus rather than a proxy – a capability that is very useful for investigating a wide range of medical conditions.” Hound Labs partnered with Triple Ring Technologies to help develop the pioneering technology.

The first HOUND MARIJUANA BREATHALYZER units are on track for availability in 4Q The HOUND MARIJUANA BREATHALYZER measures very recent marijuana use, providing on-location results as to whether an individual smoked cannabis within hours of administering the test. Interested employers and law enforcement agencies can join the Wait List2.

Hound Labs will continue to conduct IRB-approved research with the HOUND COVID BREATHALYZER. The Company is currently talking with strategic partners to conduct large-scale clinical studies and to co-develop HOUND COVID BREATHALYZERS.

About Hound Labs, Inc.
Hound Labs is a point-of-care medical technology company that combines science and technology in novel ways to improve health and wellness. The Company believes its ultra-sensitive and portable technologies will pave the way to practical and fair solutions for some of the leading public health and safety issues. Hound Labs’ point-of-care solutions include the HOUND® MARIJUANA BREATHALYZER3, which allows employers and law enforcement to identify recent marijuana use rapidly and accurately by testing breath on-site, and the HOUND® COVID BREATHALYZER, which captures breath samples on-location for laboratory identification of COVID Founded in , the Oakland-based company was co-founded by CEO, Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company.

CONTACTS

CommStrat
Linden Kohtz
[email protected]
()

Hound Labs, Inc.
Jenny Lynn, Co-Founder
[email protected]

1 http://clinchem.aaccjnls.org/content/65/9/
2 https://houndlabs.com/wait-list/
3 The HOUND® MARIJUANA BREATHALYZER is intended to detect recent marijuana use. It does not measure whether, or how much, a person is impaired. It is intended solely for use in law enforcement, employment, and insurance settings. It should not be used for any medical or therapeutic purposes, or for any Federal drug testing programs, such as programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military.

Sours: https://finance.yahoo.com/news/hound-labs-introduces-hound-covidhtml

Labs stock prices hound

Entourage effect capital

Civil 3D Pipe Networks

private equity funds invest directly in cannabis, the evolving legal Managing Director, Entourage Effect Capital. NorCal Cannabis Company is a leader in the growing California cannabis industry, having cultivated their reputation, relationships, and high quality product suite over many years. Wherever you’re at, just speed-dial your entourage. Entourage Effect Capital Co-Founder and Managing Partner Matt Hawkins joined Steve Darling from Proactive to share details about the company that has made over 70 investments in Cannabis-related companies. Planning is everything as it sets the foundation for your execution strategy. When Matt Hawkins first considered investing in ENTOURAGE EFFECT CAPITAL, LLC ( CRD# /SEC#: ) Alternate Names:ENTOURAGE EFFECT CAPITAL, LLC. Facebook is showing information to help you better understand the purpose of a Page. Ethan Russo. Because of its unique and unmatched combination of effects, this fast-growing cannabinoid has become one of the hottest items in the market, and. You might call our mortgage brokers for advice on saving for your first home deposit then, down the track, need to step into the right loan for a bigger family home. An investor for over 20 years, Hawkins has exposure Entourage Effect Capital founder and managing director Matt Hawkins has some advice for cannabis operators. Matt brings an extensive background in building large alternative investment firms and scaling the companies he Codie Sanchez is a reformed journalist, turned institutional investor to now a Managing Director and Partner at Entourage Effect Capital, a private equity firm focused specifically on investing in the legalized cannabis industry. and Tiffany Liff may have come from very different backgrounds, but together as two of the top executives at Entourage Effect Capital,  26 ม. However, if the effect persists only when one's entourage is physically present (see Fortune and Newby-Clark ), it would suggest that another mechanism underlies our effect. 30 Under 30 Recent news which mentions Hound Labs Secures $20M From Entourage Effect Capital Hound Labs Secures $20M From Entourage Effect Capital To Support Production Of Marijuana Breathalyzer September 03, Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in An investor for over 20 years, Hawkins has exposure Investors in the company include Entourage Effect Capital (EEC), Intrinsic Capital, Benchmark, Icon Ventures, and Tuatara Capital. 85). Entourage Effect Capital was an early investor in companies like Acreage, GTI and Ebbu. The term “entourage effect” is commonly used in cannabis news articles, and it doesn’t mean a group of people who love weed or those who are cannabis enthusiasts. Hound Labs, Inc. Matt Hawkins is the Managing Partner at Entourage Effect Capital, a Private Equity firm with a focus on Growth Capital for the Cannabis Industry. Matt brings an extensive background in building large alternative investment firms and scaling the companies he Research is still very much in its infancy, with regards to terpenoids and the ‘entourage effect’. CNBC's "Power Lunch" team discusses how cannabis stocks fared in and what investors should watch for in with Matt Hawkins of Entourage Effect Capital. Entourage Effect Capital is one of the largest VC firms in cannabis with over $MM deployed since its inception in He has plus years of private equity experience and has founded multiple  Codie Sanchez, Managing Director/Partner at Entourage Effect Capital, and Jeff Finkle, CEO of Arcview Ventures. Tag: entourage effect capital. So, what is the entourage effect? Coined by Israeli researchers in the late ’s, the entourage effect describes medical cannabis treatment efficacy not being limited to a specific cannabinoid such as THC or CBD Finally, and perhaps most importantly when comparing cannabis to magic mushrooms, is a phenomenon known as the entourage effect. Current investors Intrinsic Capital, Benchmark Entourage Effect Capital (formerly Cresco Capital Partners) is a United States private investment firm, dedicated to investing throughout the cannabis value chain. The entourage effect is about the interaction between THC/CBD as Dark Capital. You'll find % whole flower in every Flowerstick™. The company's File Number is listed as You'll discover:. Dark Capital. M&A, Rerating, California, Verticalization, and  Entourage Effect Capital is a private equity investment firm based in Dallas, with a focus on the cannabis industry. Entourage Effect Capital is a private equity general partner firm headquartered in Dallas, TX, United States. Entourage Effect Capital. A Full Explanation of the Cannabis Entourage Effect. You can also find it in hops and mango. #PAAA-EK2L-2W9W Sample: EST We also support business owners and companies with commercial loans, working capital and fixed asset funding. Matt Hawkins brings an extensive background in building large alternative investment firms and scaling the companies he invests in. The Entourage Effect. ค. , a health tech company, confirmed Friday that it has secured a $20 million investment to support the production of the Hound Marijuana  8 ก. Codie Sanchez is a Managing Director and Partner at Entourage Effect Capital, a private equity firm focused specifically on investing in the legalized  Covers venture capital, mergers, joint ventures, takeovers, has received $20 million from a group of private investors led by Entourage Effect Capital,  27 มี. How to tսrn into a CBD wholesaler? PCR hemp oil leans heavily on The Entourage Effect to make its claim—a mechanism via which the mixed effect of all cannabinoids and other compounds produces superior results and effects. The firm has sold most of those positions at this point, with its Entourage Effect Capital has been primarily a minority investor in Fund I and Fund II, but the firm takes an active role in working with its portfolio companies. In connection with the new fund launch, the firm has officially changed its name to Entourage Effect Capital. Founded in , Entourage Effect Capital is a private equity investment firm based in Dallas, with a focus on the cannabis industry. Report this profile Entourage Effect Capital is a private equity investment firm based in Dallas, with a focus on the cannabis industry. youtube. entourageeffectcapital. The term “Entourage Effect” is a Entourage Effect Capital is a United States private equity investment firm, dedicated to investing in the cannabis industry. Navy Capital, Global Founders Capital, Entourage Effect Capital (formerly Cresco Capital) also participated in the round. 🎙️ Podcast: Harborside Co-CEO / Entourage Effect Capital Managing Partner, Matt Hawkins. The term “Entourage Effect” is a Entourage Effect Capital General Information Description. Election Investors in the company include Entourage Effect Capital (EEC), Intrinsic Capital, Benchmark, Icon Ventures, and Tuatara Capital. Since , the firm has made close to 70 investments invested out of two funds, co-investment vehicles and special purpose Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in As you can see from the above graph (based on a property purchased for $,), the compound effect of capital growth will be $,’s of dollars extra in your pocket if you purchase the right house in the right area and properties continue to appreciate at the current rate. Essentially, the combination is more effective than the individual components. VIDEO: CNBC SEGMENT “ BEST YEAR TO INVEST IN CANNABIS” Entourage Impact Funding is among the biggest VC companies in cannabis with over £MM released because its creation in Matt Hawkins is the founder and managing partner for Dallas-based Entourage Effect Capital, the first cannabis-only venture capital firm. The Entourage Effect: Five Sharp Questions With Serene CBD. linkedin-link · Update information link Update Information · Remove profile link  Entourage Effect Capital Managing Partner sees blue sky ahead for www. Finance. The combination of Delta 8 and CBD can produce a more satisfying entourage effect than simply Delta 8 THC. Centaur Labs, a Boston-based medical data labeling company It’s a popular theme in marijuana use – the “entourage effect. Codie Sanchez, Managing Director. In , Mechoulam coined the term the “entourage effect” to describe the complicated interplay between cannabinoids and the body’s own neurotransmitters in determining the drug’s effects. The Registered Agent on file for this company is Corporation Service Company and is located at Little Falls Drive, Wilmington, DE Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a United States Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research. () For now, "folks  29 ก. an investment firm 3 ต. This is called the Entourage Effect. Founded in , Entourage Effect Capital states that its mission is to “help cannabis businesses to grow, thrive and create a positive impact four our current and future generations. “We’ve been investing in the industry since , we Entourage Effect Capital is now raising its third flagship private equity fund — with a $ million target — to focus on later-stage cannabis companies companies. Join to Connect Entourage Effect Capital. cpa. Featured. Warren Bobrow. 1, views | Investors include SOL Global Investments Corp (OTC: SOLCF), JW Asset Management, Arcadian Capital, Entourage Effect Capital and Phyto Partners. Since , EEC has poured over $ million into investments in the cannabis industry. Matt Hawkins is the Founder and Managing Partner of Entourage Effect Capital. economics favor companies with more scale, said Matt Hawkins, managing partner of private equity firm Entourage Effect Capital. Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a private investment firm, dedicated to investing in the cannabis industry. Por: Forbes Life September 01, Forbes Life September 01, Matt Hawkins is the founder and managing principal of Entourage Effect Capital (EEC), formerly known as Cresco Capital Partners, a venture capital firm focused specifically on investing in the legalized cannabis industry. Topics Discussed: Impact of Covid on the industry from the consumer perspective as well as the from the investor side Entourage Effect Capital | Matt Hawkins Episode Summary. 7 ก. The Entourage Effect is a term that is used to describe how terpenes and cannabinoids work together synergistically, rather than in isolation. Posts Tagged. Evan Veryard interviews Codie Sanchez and Matt Hawkins from Entourage Effect Capital (formerly Cresco Capital Partners) and discusses the state of private investing in cannabis. For example, when you mix the unique properties of Cannabidiol with Deltatetrahydrocannabinol (CBD and THC), you can create a physical or psychological effect that differs from if you were Join Cannabis & Tech Today Editor-in-Chief Charles Warner as he chops it up with special guest Codie Sanchez, managing director and partner at Entourage Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in The entourage effect describes a phenomenon where the most well-known "c-compounds" present in strains and extracts act in a synergistic relationship with other chemicals present in the plant called terpenes or terpenoids, to produce different and/or stronger effects than the individual compounds do alone (1). All the natural chemicals found in cannabis are ingested simultaneously. Codie Sanchez is an Active Board Member at Entourage Effect Capital, a growth equity firm focused specifically on investing in the legalized cannabis industry. Ebbu conducts never-before-published research on the effects of cannabinoids and terpenes on receptors in the body. Some of their notable  Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a United States private investment firm, dedicated to investing in the cannabis  8 ต. The entourage effect is simply a way to explain how different cannabinoids mixed together can create an effect unlike the effects of single cannabinoids. Matt Hawkins (Founder and Managing Partner) | Dov Szapiro (Managing Partner) | Joseph Blasetti (Director - Portfolio Management) | View more for Entourage  Shire Capital Advisors. Matt Hawkins is the founder and managing principal of Cresco Capital Management, LLC, a manager of Entourage Effect Capital, formerly known as Cresco Capital Partners, a private investment firm focused specifically on investing in the legalized cannabis industry. This is the third consecutive fund launched by the firm and when fully subscribed Entourage Effect Capital has put more than $ million into 65 companies. PCR hemp oil leans heavily on The Entourage Effect to make its claim—a mechanism via which the mixed effect of all cannabinoids and other compounds produces superior results and effects. Increasing the impact of your experience can lead to a more pleasant result. In , Matt had a vision to launch Entourage Effect Capital and create the leading private equity firm focused specifically on investing in the legalized cannabis Matt Hawkins is the Managing Partner at Entourage Effect Capital, a Private Equity firm with a focus on Growth Capital for the Cannabis Industry. Our mission-to provide patients and customers with the highest quality, safest cannabis medicine possible. has raised $20 million from a variety of cannabis investment groups. 0-News Brief. Current investors Intrinsic Capital, Benchmark Investors in the company include Entourage Effect Capital (EEC), Intrinsic Capital, Benchmark, Icon Ventures, and Tuatara Capital. “Transforming today’s cannabis companies into tomorrow’s industry leaders. Any single chemical in isolation does not perform in the same way that a substance will However, if the effect persists only when one's entourage is physically present (see Fortune and Newby-Clark ), it would suggest that another mechanism underlies our effect. The firm is dedicated to investing in the cannabis industry. The Entourage Effect Capital Portfolio. Invest in Entourage Effect Capital funds Hundreds of fund managers are currently fundraising on Palico. Ebbu Announces Groundbreaking Scientific Research of "Entourage Effect". Entourage are based in Melbourne, located in the Richmond and Cremorne area. Investors in the company include Entourage Effect Capital (EEC), Intrinsic Capital, Benchmark, Icon Ventures, and Tuatara Capital. Entourage Effect is one of the largest players in the cannabis industry. Read full article. likes. No plan is perfect, but all initial plans need at least a 15% variance adjustment clause as this, and Entourage Effect Capital made 18 cannabis investments last year. Privacy CNBC’s “Power Lunch” team discusses how cannabis stocks fared in and what investors should watch for in with Matt Hawkins of Entourage Effect Capital. #PAAA-EK2L-2W9W Sample: EST Financing in the space typically has come in the form of equity Matt Hawkins, founder of Entourage Effect Capital, a cannabis lender,  6 ส. For filmmaker Doug Ellin, who is as passionate about cars as he is movies, it was love at first sight. learn about serve . - Growth Equity Fund. Vice Capital Extraction N Pennsylvania Avenue Oklahoma City, OK [email protected]plususa. Current investors Intrinsic Capital, Benchmark Entourage Effect Capital has put more than $ million into 65 companies. Let’s compare rental income vs capital growth. . Vertical Companies – Total Funding: $58,, Entourage Effect Capital 10/19/ - Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/21 Jose Rodrigo Safdiye 7/23/ VC & PE firm investing in cannabis sectors. Clean & Convenient. Several of their remarkable financial investments consist of GTI, CANN, Harborside (CNQ: HBOR), Property Holdings, Ebbu, TerrAscend and also Sunderstorm. Hawkins talked about the industry as a whole and what Federal legalization could mean for the industry moving forward. In addition to Entourage Effect Capital, an investment company focused on the cannabis industry, other investors from the round included Intrinsic Capital, Benchmark, Icon Ventures and Tuatara Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in - Entourage Effect Capital. Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/ Strains of cannabis with high β-myrcene concentrations, such as those of the Indica variety, are so sedating that one Vice Capital Extractions - PAAA-EK2L-2W9W OBN Lic: Analytical Report Sample ID:M Client ID: Entourage Effectmg THC Date Received/25/ Gummy SOP:LCMS Batch: KH-1PD 11/ Analysis Date: 12/3/ Matrix: Edible Analysis Method: LC-MS/MS Analyst: DES Pesticide Result (ug/g) Action Level (ug/g) Abamectin B1a & B1b <0. Entourage Effect ILP III, LLC Funding details. One of the cannabis industry's biggest investors is a Dallas firm. D. The important person in this allegorical entourage is the overall effect that a particular strain of cannabis has on the human body — whether or not it makes you dozy or invigorates you, chills you out or makes you edgy, dulls your pain or heightens your senses, or any combination of a plenitude of potential effects. Matt Hawkins is the founder and managing principal of Entourage Effect Capital (EEC), formerly known as Cresco Capital Partners, a venture capital firm focused specifically on investing in the legalized cannabis industry. Investors include SOL Global Investments Corp (OTC: SOLCF), JW Asset Management, Arcadian Capital, Entourage Effect Capital and Phyto Partners. The company raised the funds in order to scale production of the HOUND MARIJUANA BREATHALYZER. 5B in deals across VC, private Entourage Effect Capital (formerly Cresco Capital Partners) is a US private investment company specializing in investments across the cannabis value chain. Entourage Effect Capital To Raise New $ Million Private Equity Cannabis Fund Entourage Effect Capital's new fund will target later-stage cannabis companies. This world is mainly used in the cannabis field. 5 The important person in this allegorical entourage is the overall effect that a particular strain of cannabis has on the human body — whether or not it makes you dozy or invigorates you, chills you out or makes you edgy, dulls your pain or heightens your senses, or any combination of a plenitude of potential effects. Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a United States private investment firm, dedicated to investing in the cannabis industry. Private Equity Investing in Cannabis Industry Companies ONE Cannabis; Matt Hawkins, Managing Partner, Entourage Effect Capital LLC  14 พ. An inside look at Entourage Effect Capital and how it’s evolved since it was founded in New ways to invest in cannabis and opportunities that still remain untapped How valuations for private cannabis investments have changed over the last couple of years Entourage Effect Capital. Daily Forum) Hemp Industry Daily Forum (Tuesday, Oct. ”. Since its inception in the summer of , EEC has deployed $+ million into over 65 companies out of its two Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in ” When entourageeffectcapital posts, you'll see their  29 มี. The Entourage Effect says that the whole is greater than the sum of the parts. Por: Forbes Life September 01, Forbes Life September 01, Entourage Effect Capital, LLC is a Delaware Limited-Liability Company filed On November 7, Hound Labs says it has developed a […] The news that Entourage Effect Capital, Dallas is now projected to double to almost 40 billion USD by the year is befuddling for two reasons to a layman. Florida State University. Entourage Effect Capital (EEC), a private investment firm dedicated to investing in high-quality emerging growth cannabis companies, led the round. Plus Strain: Entourage Effect - 25mg THC Watermelon Batch#: WM CB 06/; Batch Size: g Sample Received: 06/17/ Report Created: 06/24/ Expires: 09/22/ Entourage Effect - 25mg “We’re interested in the concept of the entourage effect, with the idea being that maybe we can boost the modest pain-relieving efficacy of THC and not boost the psychoactive side effects, so you could have a better therapeutic,” explains John Streicher, Ph. Codie Sanchez is a Managing Director and Partner at Entourage Effect Capital, a venture capital and private equity fund in the legalized cannabis space with $+M in AUM and has just launched its third dedicated fund for $MM, making them one of the largest PE funds in the industry. Whether it’s general advising or full-fledged cannabis/hemp industry business plans, The Entourage Effect will bring it all together cohesively. ” Company profile page for Entourage Effect Capital LLC including stock price, company news, press releases, executives, board members, and contact information In addition to Entourage Effect Capital, an investment company focused on the cannabis industry, other investors from the round included Intrinsic Capital, Benchmark, Icon Ventures and Tuatara Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in , the study’s lead researcher and an associate professor of pharmacology at Finally, and perhaps most importantly when comparing cannabis to magic mushrooms, is a phenomenon known as the entourage effect. With the launch of what's known as Fund III, the firm is changing its name to Entourage Effect Capital, in reference to the synergistic  The latest Tweets from entourage effect capital (@EEffectCapital): "Earlier this month, @mgretailer reported that @curiowellness announced the application  Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a United States private investment firm, dedicated to investing in the cannabis  Entourage Effect Capital “Transforming today's cannabis companies into tomorrow's industry leaders. Entourage Effect Capital; Cannabis Legalization as a tool for Economic Recovery, by Thomas Roth, Director of Regulatory Services, Akerna  11 ก. Centaur Labs, a Boston-based medical data labeling company, raised $15 million in Series A funding. Cannabidiol (CBD) is under preliminary research for its potential to modify the effects of THC, possibly mitigating some of the negative, psychosis Entourage Effect Capital led the round, which saw participation from Intrinsic Capital, Benchmark, Icon Ventures and Tuatara Capital. managing partner of private equity fund Entourage Effect Capital, for companies that have strong cash and capital positions. com () Lic. It is a common concept that is current in holistic drugs and remedy, for instance. 23 ม. Since its inception in the summer of , EEC has deployed $+ million into over 65 companies out of its two Entourage Effect Capital Server. Entourage Effect Capital Virdian Capital Advisors Physicians, hospitals and health systems; Private equity funds  The Company has received indicative lead orders totaling approximately US$15 million from Executive Chairman Jason Ackerman, Entourage Effect Capital,  Video Episode 57 Codie Sanchez Of Entourage Effect Capital Eec, “DEX 3 is the one all in a single solution to choose from it enables me to  15 พ. - #private-equity #HedgeMaven Evan Veryard interviews Codie Sanchez and Matt Hawkins from Entourage Effect Capital (formerly Cresco Capital Partners) and discusses the state of private investing in cannabis. Matt Hawkins of Entourage Effect offers high-net-worth individuals and family offices access to the legalized cannabis industry. The team will take board seats and Entourage Effect Capital, formerly Cresco Capital Partners, is a US private equity investment firm, dedicated to investing in the cannabis industry. - Formerly known as Cresco Capital Partners www. In , Matt had a vision to launch Entourage Effect Capital and create the leading private equity firm focused specifically on investing in the legalized cannabis Entourage Effect Capital | Matt Hawkins Episode Summary. Matt Hawkins is the founder and managing principal of Entourage Effect Capital (EEC), formerly known as Cresco Capital Partners,  Arcadian Capital is a leader in cannabis venture capital and headquartered in the Entourage Effect Capital, LLC (formerly Cresco Capital Partners,  Matt Hawkins is the Founder and Managing Partner of Entourage Effect Capital. Such examples previously stated only scratch the surface of the potential therapeutic and medicinal value these terpenoids can offer by working in synergy with the many cannabinoids present in the cannabis plant. With $M in AUM, and having just launched their third dedicated fund for $MM, they are one of the largest PE funds in the industry. ” It’s defined as the broad-spectrum sense of wellness derived from consuming an unaltered or concentrated form of cannabis. June 23 The term "entourage" is commonly used to describe hemp products that contain the full spectrum profile of the marijuana plant and can enable the entourage effect. The term "entourage" is commonly used to describe hemp products that contain the full spectrum profile of the marijuana plant and can enable the entourage effect. พ. Real World Retail; Strategies (Hemp Industry. June 23 Badger State Hemp Company. The fund's portfolio includes the data company BDS Analytics and the consumer-cannabis startup Sublime, whose products include Entourage Effect Capital is now raising its third flagship private equity fund — with a $ million target — to focus on later-stage cannabis companies companies. - #private-equity #HedgeMaven Entourage Effect ILP III, LLC Funding details. New Covid created canna-business opportunities Casual investors have learned that the rapidly evolving nature of the cannabis industry makes it difficult to find good cannabis investments. Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“CCP”), a private equity firm focused  20 เม. us/coa/ Recent filings for Project Entourage Effect Capital Co-Founder and Managing Partner Matt Hawkins joined Steve Darling from Proactive to share details about the company that has made over 70 investments in Cannabis-related companies. Vertical Companies – Total Funding: $58,, I’ve seen that you’re interested in something called ‘the entourage effect’, do you mind giving me an overview of what the entourage effect is? Entourage is a word that applies to combinations of compounds. 19) Entourage Effect Capital To Raise New Private Equity Fund Focusing On Later-Stage Cannabis Companies. With SAFE Banking being introduced in Congress on Thursday, TDR sat down with Entourage Effect Capital's Matt Hawkins to discuss where he believes the regula Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in state. The term is used to describe the synergy between the combination of different chemical combinations in cannabis. West Capitol Drive, Brookfield, Wisconsin , United States. Entourage Effect Capital led the round, which saw participation from Intrinsic Capital, Benchmark, Icon Ventures and Tuatara Capital. This entourage effect is a missing ingredient in the current psychedelic drug development The entourage effect has been observed elsewhere in the plant world, while its appearance in cannabis has been discussed in dozens of scientific publications, including the British Journal of Pharmacology, which in published an influential paper on the topic by neurologist and cannabis researcher Dr. serve capital partners. Visit SEC Site. His company was an early pioneer in the sector, having allocated over $ million into 65 companies since 26 ก. Marijuana, gold, oil, emerging markets and micro caps are just some of the investing themes industry pros expect to work in the year ahead. Entourage Effect Capital (formerly Cresco Capital), Bengal Capital and Pura Vida Investments each invested recently. The entourage effect entered the marijuana industry’s consciousness a couple of decades ago, and most MJ businesses today have a basic understanding of it, noted Brad Bogus, vice president of growth and marketing at Confident Cannabis, a California firm that offers an online software platform for testing labs, producers and retailers. Codie Sanchez is a Managing Director and Partner at Entourage Effect Capital, a venture capital and private equity fund in the legalized cannabis space. Join Cannabis & Tech Today Editor-in-Chief Charles Warner as he chops it up with special guest Codie Sanchez, managing director and partner at Entourage Effect Capital (EEC). Why VCs like the company: "We invested in Holistic which to my mind is a top Business Planning. 1, views | I’ve seen that you’re interested in something called ‘the entourage effect’, do you mind giving me an overview of what the entourage effect is? Entourage is a word that applies to combinations of compounds. View domain name system records, including but not limited to the A, CNAME, MX, and TXT records. Founded in , the Firm has approximately Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in Although few U. Why VCs like the company: "We invested in Holistic which to my mind is a top Matt Hawkins of Entourage Effect Capital told Bryan that from his perspective the industry is in good shape despite the impact of COVID 5 Vice Capital Extraction N Pennsylvania Avenue Oklahoma City, OK [email protected] S. Current investors Intrinsic Capital, Benchmark Entourage Effect Capital. This has played out in the Cannabis space and there is mounting evidence that synthetic psychedelics do not produce an entourage effect. We were one of the first private growth equity funds in the cannabis industry, and we’ve allocated over $ million since into over 65 companies, across multiple funds. β-myrcene is the most common terpene found in cannabis. An investor for over 20 years, Hawkins has exposure Cannabis breathalyzer company Hound Labs, Inc. When Matt Hawkins first considered investing in Entourage Effect Capital, formerly Cresco Capital Partners, is a US private equity investment firm, dedicated to investing in the cannabis industry. Pre-filled sticks with no grinding, packing or cleaning*. Entourage Impact Funding is among the biggest VC companies in cannabis with over £MM released because its creation in He has 20+ years of private equity experience and has founded multiple $+MM alternative firms. 5 0. Since , the firm has made close to 70 investments invested out of two funds, co-investment vehicles and special purpose With SAFE Banking being introduced in Congress on Thursday, TDR sat down with Entourage Effect Capital's Matt Hawkins to discuss where he believes the regula Entourage Effect Capital Co-Founder and Managing Partner Matt Hawkins joined Steve Darling from Proactive to share details about the company that has made over 70 investments in Cannabis-related companies. com. Entourage Effect Capital To Raise New Private Equity Fund Focusing On Later-Stage Cannabis Companies. The entourage effect describes a phenomenon in which all of the compounds in cannabis, including cannabinoids and terpenes, act in synergy to  16 ก. Strain: Entourage Effect- 25mg THC Watermelon Gummy Batch#: WM RC 05/; Batch Size: g Sample Received: 05/17/ Report Created: 05/17/ Expires: 08/15/ A Crash Course on the Entourage Effect Terpenes are known for providing therapeutic effects when combined in the right doses with other cannabinoids, such as THC or CBD. CNBC’s “Power Lunch” team discusses how cannabis stocks fared in and what investors should watch for in with Matt Hawkins of Entourage Effect Capital. Both cannabis and magic mushrooms contain different chemical compounds that work in harmony to help produce that specific strains’ effects. 31 มี. Finance and Home Loans. Leave a Comment / Health & Fitness::Fitness Equipment / By jamelblocker Checkout the great smoking products and accessories from our partners. Scaling from a seed of inspiration in , Holistic Industries is now one of the largest, fastest growing private Multi-State Operators in the country. An investor for over 20 years, Hawkins has exposure across the country, spanning large operators, tech, science, licensing, real estate, ancillary services and other sectors. Entourage Effect Capital, formerly Cresco Capital Partners, is a US private equity investment firm, dedicated to investing in the cannabis  Entourage Effect Capital, formerly Cresco Capital Partners, is a venture capital and private equity firm investing in cannabis companies that is  Entourage Effect Capital. - Dickinson Wright. 5 พ. ย. Research is still very much in its infancy, with regards to terpenoids and the ‘entourage effect’. an investment firm focused on lower middle-market private equity opportunities. Scot Crow, Practice Group Chair. Strains of cannabis with high β-myrcene concentrations, such as those of the Indica variety, are so sedating that one Entourage Effect Capital led the round, which saw participation from Intrinsic Capital, Benchmark, Icon Ventures and Tuatara Capital. Entourage Effect Capital Server. This terpene is known to produce a sedating and relaxing effect on the body. The Entourage Effect and Psychedelics. Start Trading >>. Also at the marijuana industry's biggest event, Codie Sanchez, managing director at cannabis private equity firm Entourage Effect Capital,  An entrepreneur, investor and speaker, Codie Sanchez is Managing Director and Partner at Entourage Effect Capital, a venture capital and private equity fund  31 พ. Visual Web Stories. Matt Hawkins is a Managing Partner at Entourage Effect Capital—formerly Cresco Capital Partners—a private investment company based in the United States that specializes in cannabis industry investments. We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy. July 23, , A Q&A with Matt Hawkins, Co-Founder & Managing Partner at Entourage Effect Capital {$excerpt:n} The cannabis industry saw close to $ One, comprehending the magnitude of success and fame that a small business from Dallas is quite a challenge itself. Visit the SEC's Investment Adviser Public The news that Entourage Effect Capital, Dallas is now projected to double to almost 40 billion USD by the year is befuddling for two reasons to a layman. Entourage Effect Capital marijuana Will the 87th Texas Legislature Expand Access to Medicinal Marijuana? By Will Maddox | 8 months ago Past sessions have not been promising, but advocates are Matt Hawkins, CEO of Entourage Effect Capital. com/watch?v=SjCVKOKUSjg Entourage Effect Capital Co-Founder and Managing Partner Matt Hawkins joined Steve Darling from Proactive to share details about the company  4 ต. GTM-KSV23F2 DNS. Topics Discussed: Impact of Covid on the industry from the consumer perspective as well as the from the investor side Entourage Effect Capital Co-Founder and Managing Partner Matt Hawkins joined Steve Darling from Proactive to share details about the company that has made over 70 investments in Cannabis-related companies. Centaur Labs, a Boston-based medical data labeling company CNBC’s “Power Lunch” team discusses how cannabis stocks fared in and what investors should watch for in with Matt Hawkins of Entourage Effect Capital. Editors' Picks. Research out of Australia is indicating the “entourage effect” associated with medicinal cannabis is likely really a thing. No trim, or chemicals additives. Vice Capital Extractions - PAAA-EK2L-2W9W OBN Lic: Analytical Report Sample ID:M Client ID: Entourage Effectmg THC Date Received/25/ Gummy SOP:LCMS Batch: KH-1PD 11/ Analysis Date: 12/3/ Matrix: Edible Analysis Method: LC-MS/MS Analyst: DES Pesticide Result (ug/g) Action Level (ug/g) Abamectin B1a & B1b <0. The entourage effect is a proposed mechanism by which cannabis compounds other than tetrahydrocannabinol (THC) act synergistically with it to modulate the overall psychoactive effects of the plant. VIDEO: CNBC SEGMENT “ BEST YEAR TO INVEST IN CANNABIS” Cannabisinstore. tx. Established in , Entourage Effect Capital is a private equity investment firm based in Dallas, Texas. % Whole Flower . Squarespace GTM ID. Entourage Effect ILP III, LLC raised $14,, from 14 investors on Your entourage is ready to grow with you, giving you what you need when you need it. EEC’s mission is to actively leverage our sector and investment experience, networks, and investment process, and to identify, invest and accelerate high quality emerging growth companies. Jose Rodrigo Safdiye. Cannabisinstore. What is the entourage effect. We were one of the first private growth equity funds in the cannabis industry, and have invested over $ million in over 70 companies across multiple funds since Their three managing partners, Matt Hawkins, Andy Sturner, and Dov Szapiro, have a combined 65+ years of venture experience and are not planning on slowing down anytime soon. Matt also serves on the board of numerous cannabis companies. entourage effect capital Cresco Capital Partners, a private equity investment firm focused solely on making strategic investments in the  23 ก. Participants read one of the three scenarios and then completed the felt status measure, which was assessed using the same items as described in study 2 (α = . 31 ธ. Entourage Effect Capital marijuana Will the 87th Texas Legislature Expand Access to Medicinal Marijuana? By Will Maddox | 8 months ago Past sessions have not been promising, but advocates are Matt Hawkins is the Founder and Managing Partner of Entourage Effect Capital. Managing Partner Matt Hawkins spoke with New Cannabis Ventures about Entourage Effect Capital's close relationship with Harborside and the future of the  15 ม. Entourage Effect Capital managing partner Matt Hawkins has been active in the cannabis space since creating his private equity firm in Entourage offer home loans, expert finance advice and mortgage broking. Entourage Effect Capital (EEC), formerly known as Cresco Capital Partners, is a private cannabis fund disrupting the rapidly evolving cannabis industry. EEC has deployed close to $ million into over 65 companies out of its three dedicated funds and co-investment vehicles. Vice Capital Extractions - PAAA-EK2L-2W9W OBN Lic: Analytical Report Sample ID:M Client ID: Entourage Effect-THC Vape Date Received: 8/17/ Cart Black Lime SOP:CANN Batch: BL D CE 05/ Analysis Date: 8/19/ Matrix: Other Analysis Method: HPLC/DAD Analyst: CNE Cannabinoid Result (%) Result (μg/g) CBDa ND ND CBG 9 A Full Explanation of the Cannabis Entourage Effect. com is your last stop for the best canna related news and guides. Former Contributor. ” Entourage Effect Capital. Hound Labs says it has developed a patented and one-of-a-kind ultra-sensitive technology that is at the core of the Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a United States Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research. Our distinguished executive team brings more than two decades of expertise and business acumen and executes a vertical integration strategy that optimizes the balance Managing Director at Entourage Effect Capital Miami-Fort Lauderdale Area + connections. "I would say to the small to mid-sized operators -- no matter what sector you're in Matt Hawkins, CEO of Entourage Effect Capital. Entourage Effect Capital, LLC, agent; Entourage Effect General Partner III, LLC, manager; Registry Page https://mycpa. Matt Hawkins, founder and managing partner at cannabis focused private-equity firm Entourage Effect Capital, welcomed the news. An investor for over 20 years, Hawkins has exposure Holistic Industries is building a great place to work, shop and invest in cannabis. Cannabidiol (CBD) is under preliminary research for its potential to modify the effects of THC, possibly mitigating some of the negative, psychosis Entourage Effect Capital (formerly Cresco Capital), Bengal Capital and Pura Vida Investments each invested recently. They have allocated over $M into 65+ companies since Codie Sanchez is a reformed journalist, turned institutional investor to now a Managing Director and Partner at Entourage Effect Capital, a private equity firm focused specifically on investing in the legalized cannabis industry. 5-year-old fatally shoots 3-year-old in Minnesota, officials say. It uses its combined professional, political, and community resources to source investment opportunities throughout the supply chain from genetics and farming to retail, branding, and distribution. Hound Labs says it has developed a patented and one-of-a-kind ultra-sensitive technology that is at the core of the Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/

Sours: http://win.vet.hr/ibjtq/dqzf.php?qfqs=entourage-effect-capital
hound labs is the first dual alcohol \u0026marjiuana( GANJAI) breathalyzer manufacturer.
https://www.profitconfidential.com/marijuana/thc-breathalyzers-invest-now-cannabis-technology/ Marijuana THC Breathalyzers: How to Invest Now in This Cannabis Technology Gaurav S. Iyer, IFC Profit Confidential TZ Cannabix stockCannabix TechnologiesOTCMKTS:BLOZFCVE:WPOBLZOF stockHound Labsmarijuana breathalyzermarijuana stockAs the Marijuana trend grows, we take a look at the explosive niche in the marijuana stocks market. THC breathalyzer could be the next big thing in the marijuana market apart from marijuana growers and medicinal uses. Marijuana https://www.profitconfidential.com/wp-content/uploads//04/marijuana-breathalyzerxjpg [caption id="attachment_" align="alignleft" width=""]Marijuana Breathalyzer iStock.com/sylv1rob1[/caption]

Why Invest in Marijuana THC Breathalyzer Stocks?

Everyone knows that marijuana stocks outperformed in , but few people are aware of this small, explosive niche in the cannabis market: marijuana breathalyzer stocks. This growing trend is excellent for equities like the two companies we'll look at below. First, though, we have to consider why there is surging demand for marijuana tetrahydrocannabinol (THC) breathalyzers in the first place. The answer is, of course, public safety. Pot smokers are notoriously casual about the risks of smoking and driving. A recent survey showed that 40% of marijuana users drove less than two hours after smoking, which is less than half the wait time suggested by U.S. authorities. So whether you agree with marijuana legalization, there’s no denying that smoking and driving is an extremely dangerous thing to do. Studies have found a “direct relationship between blood THC concentration and impaired driving ability.” (Source: "Does marijuana use affect driving?," National Institute on Drug Abuse, last accessed April 24, ) To make matters worse, we have virtually no idea what happens when people mix marijuana consumption with alcohol consumption. All we can say for sure is that the effects of each substance are compounded. In other words, legalizing marijuana is a nightmare for law enforcement. With alcohol, there is an established procedure: walk in a straight line, count backwards from , and blow into this breathalyzer. But with marijuana, there’s no way of establishing whether someone is inebriated. Enter, marijuana breathalyzers. These devices are exactly what they sound like: handheld tools that police use to measure THC content. Almost everyone is on board with them, aside from a few hippies and libertarian nutjobs, meaning there is a market opportunity here. Think about it: 29 U.S. states have legalized cannabis in one form or another. All of these jurisdictions will need a clear, objective way of scouting impaired drivers. THC breathalyzers seem like the obvious answer. There are two companies that manufacture marijuana breathalyzers: Cannabix Technologies Inc (OTCMKTS:BLOZF, CVE:WPO) and a San Francisco-based startup called Hound Labs, Inc. Although both companies are promising, retail investors can only invest in the former. Since Hound Labs is still a private company, you can't find Hound Labs stock listed on a stock exchange. Hound Labs got an $million funding round from Benchmark Capital, a major venture capital company that made early bets on Uber Technologies Inc., Snap Inc (NYSE:SNAP), Dropbox Inc. (NASDAQ:DBX), and WeWork. So maybe we’ll hear more about Hound Labs down the road. But for now, there’s no point in discussing the company's valuation because retail investors don’t have access to its funding rounds. Cannabix stock, on the other hand, is a small-cap marijuana stock that trades at roughly $ Let's take a closer look at that particular investment opportunity. Chart courtesy of StockCharts.com

Cannabix Technologies News

Cannabix (and Hound Labs) are trying to do something that no one has done before: quantify the intoxication level of marijuana users without a blood test. That’s an uphill task. Trace compounds from marijuana stay in the bloodstream for days and weeks afterward, meaning that blood samples can’t show if someone is high right now. Marijuana breathalyzers would solve that problem by measuring THC on someone’s breath. Cannabix is using field asymmetric waveform ion mobility spectrometry (FAIMS) for its devices. Catchy name, right? The company filed a second patent to that effect on April 16, thereby layering each new beta test with greater legal protection. However, there’s still one glaring problem with the innovative technology. No one knows how much marijuana is too much. For alcohol, there’s a well-accepted threshold of % of alcohol in your bloodstream. What’s the marijuana equivalent? Is it higher or lower? Law enforcement officials are still grappling with this question, which, in other words, means that marijuana measurements are pretty toothless at the moment.

Should I Invest in Cannabix Stock?

Tough question. On one hand, Cannabix Technologies is obviously in the right place at the right time. It is a small-cap marijuana stock at the heart of an emerging trend. Marijuana legalization is sweeping across North America (notwithstanding U.S. Attorney General Jeff Sessions), investors are looking for yield, and only a handful of competitors exist. Cannabix has a chance to capture lightning in a bottle if it can perfect marijuana breathalyzers, but that’s the sticking point—if it can perfect the technology. There is no guarantee. This situation reminds me of biotech stocks. You bet on the possibility of drug approval by the U.S. Food and Drug Administration (FDA). If you bet right, it’s straight to the penthouse. If you bet wrongwell, investing is a risky business. Put another way, Cannabix Technologies is a company with no revenues, but it has millions of dollars in research and development (R&D). No wonder the market is “hot and cold” on Cannabix stock. You can see that, last year, investors were flying high on the stock, doubling the share price within a matter of months. When the broader market took a tumble at the start of the year, however, BLOZF stock went down harder and faster than most. Why? Because it has very little to stand on, other than the promise of future contracts and perfected technology.

Analyst Take

To recap, Cannabix stock has both extreme upside and downside. It is a play for risk capital investors. As such, my BLOZF stock forecast is split between the short and long terms. I believe that investors can “trade the rumor, sell the news” on this one, because, sooner or later, governments are going to need devices to use on roadside marijuana stops. That could lead to resurgence in investor optimism, but it won’t last for long. Eventually, Cannabix will become vulnerable to a long product cycle. It also has very few options for sideways growth, meaning that its bright spark will probably fizzle out.
Sours: https://www.profitconfidential.com/marijuana/thc-breathalyzers-invest-now-cannabis-technology/

Now discussing:

Nods towards San Sanych. - And I'm his wife. Do not be afraid, I will not fight with you and I will not hurt you. In the end, you got the money and now you have to fulfill the client's wishes. Today your client is me.



4802 4803 4804 4805 4806